Teva Pharma Reaches Settlement with Pfizer over Celebrex Patent
In a statement, Pfizer confirms a settlement agreement with Teva as to the manufacture of a generic version of Celebrex but maintains the validity of its existing patent over the drug.
In a statement, Pfizer confirms a settlement agreement with Teva as to the manufacture of a generic version of Celebrex but maintains the validity of its existing patent over the drug.